William JL Rieflin's Net Worth
$16.2 Million
Who is William JL Rieflin?
William JL Rieflin has an estimated net worth of $16.2 Million. This is based on reported shares across multiple companies, which include Anacor Pharmaceuticals, Inc., NGM BIOPHARMACEUTICALS INC, RAPT Therapeutics, Inc., Lyell Immunopharma, Inc., XENOPORT INC, and TULARIK INC.
SEC CIK
William JL Rieflin's CIK is 0001182471
Past Insider Trading and Trends
2010 was William JL Rieflin's most active year for acquiring shares with 9 total transactions. William JL Rieflin's most active month to acquire stocks was the month of April. 2016 was William JL Rieflin's most active year for disposing of shares, totalling 19 transactions. William JL Rieflin's most active month to dispose stocks was the month of July. 2016 saw William JL Rieflin paying a total of $741,080.00 for 114,000 shares, this is the most they've acquired in one year. In 2016 William JL Rieflin cashed out on 606,101 shares for a total of $11,855,360.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Anacor Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -89.85K |
$99.25 | -$8,917,910.25 |
0
|
Jun 24
| |||
Form 4
|
∞
| 89K |
$8.33 | $741,080.00 | 89K |
Mar 31
| |||
Form 4
|
∞
| 853 |
—
|
—
| 853 |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NGM BIOPHARMACEUTICALS INC (NGM) Snapshot price: $1.44
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.77M |
—
|
—
|
0
|
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +2.09% | 56.67K |
—
|
—
| 2.77M |
Apr 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RAPT Therapeutics, Inc. (RAPT) Snapshot price: $25.855
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
| +125.00% | 10K |
$16.22 | $162,200.00 | 18K |
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +408.35% | 68.06K |
$12.00 | $96,000.00 | 84.72K |
Nov 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lyell Immunopharma, Inc. (LYEL) Snapshot price: $1.91
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
XENOPORT INC No price found
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -312.85K |
$7.03 | -$2,199,300.35 |
0
|
Jul 5
| |||
Form 4
| +18.75% | 5K |
—
|
—
| 31.66K |
May 17
| |||
Form 4
| +23.08% | 5K |
—
|
—
| 26.66K |
May 19
| |||
Form 4
| -33.70% | -11.01K |
$8.49 | -$93,474.90 | 21.66K |
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +18.07% | 5K |
—
|
—
| 32.67K |
May 14
| |||
Form 4
| +22.06% | 5K |
—
|
—
| 27.67K |
May 14 - May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
| +3.69% | 10K |
$3.86 | $38,580.00 | 281.12K |
Dec 16
| |||
Form 4
| +3.83% | 10K |
$4.44 | $44,413.00 | 271.12K |
Nov 21
| |||
Form 4
| +1.95% | 5K |
$5.49 | $27,451.50 | 261.12K |
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
| +1.76% | 399 |
—
|
—
| 23.07K |
Sep 16 - Sep 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
| +16.04% | 2.92K |
—
|
—
| 21.11K |
Feb 24
| |||
Form 4
| +7.38% | 1.25K |
—
|
—
| 18.19K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 4
| +9.91% | 1.46K |
—
|
—
| 16.19K |
Feb 17
| |||
Form 4
| +9.27% | 1.25K |
—
|
—
| 14.73K |
Jan 28 - Jan 30
| |||
Form 4
| +2.17% | 5.59K |
—
|
—
| 263.09K |
Dec 15 - Jan 14
| |||
Form 4
| +14.45% | 18.89K |
$15.00 | $283,305.00 | 149.61K |
Nov 10
| |||
Form 4
| +25.05% | 1.46K |
—
|
—
| 7.28K |
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
| 230.67K |
Dec 10 - Jan 30
| |||
Form 4
| -1.17% | -2.79K |
—
|
—
| 235.48K |
Feb 27 - Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
| -1.30% | -3.15K |
—
|
—
| 238.28K |
Sep 15 - Nov 6
| |||
Form 4/A
| +0.96% | 2.27K |
$8.93 | $20,277.60 | 238.94K |
Nov 16
| |||
Form 4
| +0.85% | 2.27K |
$8.93 | $20,277.60 | 268.94K |
Nov 16 - Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||